BackShanghai ZJ Bio-Tech , Ltd. Overview

Shanghai ZJ Bio-Tech , Ltd. Total Current Liabilities

Shanghai ZJ Bio-Tech , Ltd.'s total current liabilities is $110M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$109.72M
↓ 13.87% YoYΔ $-17.67M vs prior year quarter

Peer trimmed avg / median

Loading

Shanghai ZJ Bio-Tech , Ltd. Total Current Liabilities History

Loading

Shanghai ZJ Bio-Tech , Ltd. vs. peers: Total Current Liabilities Comparison

Loading

Shanghai ZJ Bio-Tech , Ltd. Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Shanghai ZJ Bio-Tech , Ltd. (688317.SS) FAQ

Shanghai ZJ Bio-Tech , Ltd. (688317.SS) currently reports a total current liabilities of $110M as of September 2026. That compares with $130M in the prior-year period — down 13.9% year over year. Use the charts on this page to explore Shanghai ZJ Bio-Tech , Ltd.'s total current liabilities history and peer comparisons.

Shanghai ZJ Bio-Tech , Ltd.'s total current liabilities decreased from $130M to $110M — a 13.9% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Shanghai ZJ Bio-Tech , Ltd. reported $110M in total current liabilities as of September 2026. That compares with $130M in the prior-year period — down 13.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Shanghai ZJ Bio-Tech , Ltd., and consider following 688317.SS for alerts when major investors trade the stock.

Shanghai ZJ Bio-Tech , Ltd. is classified in the Healthcare sector. On total current liabilities, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 688317.SS with unrelated industries.